Literature DB >> 15978224

Lasers for lower urinary tract symptoms secondary to benign prostatic hyperplasia: when is the fuss worth it?

Werner W Hochreiter1, Roger M Müller.   

Abstract

In the recent past, several endoscopic procedures using laser technology have evolved for the treatment of benign prostatic hyperplasia. The term "laser treatment of the prostate" comprises a variety of different application systems, different laser wavelengths, and different surgical techniques to eliminate bladder outlet obstruction. The aim of laser prostatectomy is to be less invasive than transurethral electroresection, but equally effective. Promising short-term results led to a booming laser decade in the 1990s, stimulating the development of several devices. However, the emergence of medium-term data has shown that some of these techniques did not stand the test of time due to the lack of long-term efficacy, unacceptable morbidity, and high retreatment rates. Nevertheless, the results of transurethral resection of the prostate are challenged by some of the newer laser devices, putting the so-called "gold standard" into question.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978224     DOI: 10.1007/s11934-005-0018-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  56 in total

1.  Holmium laser resection of the prostate is more cost effective than transurethral resection of the prostate: results of a randomized prospective study.

Authors:  M R Fraundorfer; P J Gilling; K M Kennett; N G Dunton
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

2.  AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.

Authors: 
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

3.  Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience.

Authors:  P J Gilling; K Kennett; A K Das; D Thompson; M R Fraundorfer
Journal:  J Endourol       Date:  1998-10       Impact factor: 2.942

Review 4.  Holmium laser resection of the prostate.

Authors:  A Le Duc; P J Gilling
Journal:  Eur Urol       Date:  1999-02       Impact factor: 20.096

5.  Transurethral evaporation of the prostate for treatment of benign prostatic hyperplasia: results in 168 patients with up to 12 months of followup.

Authors:  P Narayan; A Tewari; E Schalow; R Leidich; S Aboseif; C Cascione
Journal:  J Urol       Date:  1997-04       Impact factor: 7.450

6.  First clinical experiences on neodymium-YAG laser irradiation of localized prostatic cancer.

Authors:  H O Beisland; S Sander
Journal:  Scand J Urol Nephrol       Date:  1986

7.  [Transurethral resection of the prostate with the Holmium contact laser. Progress in treatment of benign prostatic hypertrophy?].

Authors:  W Hochreiter; C Hugonnet; U E Studer
Journal:  Urologe A       Date:  1999-03       Impact factor: 0.639

8.  Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up.

Authors:  P J Gilling; K M Kennett; M R Fraundorfer
Journal:  J Endourol       Date:  2000-11       Impact factor: 2.942

9.  Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study.

Authors:  C G Roehrborn; M M Issa; R C Bruskewitz; M J Naslund; J E Oesterling; R Perez-Marrero; B P Shumaker; P Narayan
Journal:  Urology       Date:  1998-03       Impact factor: 2.649

10.  Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial.

Authors:  Alexis E Te; Terrence R Malloy; Barry S Stein; James C Ulchaker; Unyime O Nseyo; Mahmood A Hai; Reza S Malek
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.